Predicting Response to Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Blockade in NSCLC—Is Multiplex Immunohistochemistry or Immunofluorescence the Answer?

Programmed Death ◽

Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death‐Ligand 1 Blockade: A Case Discussion and Review of the Literature

The Oncologist ◽

10.1634/theoncologist.2019-0671 ◽

2020 ◽

Vol 25 (5) ◽

pp. 369-374 ◽

Cited By ~ 3

Author(s):

Miruna Grecea ◽

Aurélien Marabelle ◽

Samy Ammari ◽

Christophe Massard ◽

Stéphane Champiat

Keyword(s):

Cell Death ◽

Programmed Cell Death ◽

Review Of The Literature ◽

Case Discussion ◽

Programmed Death ◽

Hyperprogressive Disease ◽

Circulating MicroRNAs and Extracellular Vesicle–Containing MicroRNAs as Response Biomarkers of Anti–programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLC

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2020.05.022 ◽

2020 ◽

Vol 15 (11) ◽

pp. 1773-1781 ◽

Cited By ~ 4

Author(s):

Takehito Shukuya ◽

Vikas Ghai ◽

Joseph M. Amann ◽

Tamio Okimoto ◽

Konstantin Shilo ◽

...

Keyword(s):

Cell Death ◽

Programmed Cell Death ◽

Extracellular Vesicle ◽

Circulating Micrornas ◽

Programmed Death ◽

Response Biomarkers ◽

The role of the programmed cell death protein-1/programmed death-ligand 1 pathway, regulatory T cells and T helper 17 cells in tumor immunity: a narrative review

Annals of Translational Medicine ◽

10.21037/atm-20-6719 ◽

2020 ◽

Vol 8 (22) ◽

pp. 1526-1526

Author(s):

Lanfang Zhang ◽

Mingjuan Zhang ◽

Jinxiu Xu ◽

Shan Li ◽

Yu Chen ◽

...

Keyword(s):

T Cells ◽

Cell Death ◽

Programmed Cell Death ◽

T Helper ◽

T Helper 17 ◽

T Helper 17 Cells ◽

Programmed Death ◽

Programmed cell death protein-1/programmed death-ligand 1 blockade enhances the antitumor efficacy of adoptive cell therapy against non-small cell lung cancer

Journal of Thoracic Disease ◽

10.21037/jtd.2018.10.111 ◽

2018 ◽

Vol 10 (12) ◽

pp. 6711-6721 ◽

Cited By ~ 2

Author(s):

Jingyi Chen ◽

Yusong Chen ◽

Fenglan Feng ◽

Cheng Chen ◽

Haikang Zeng ◽

...

Keyword(s):

Lung Cancer ◽

Cell Death ◽

Programmed Cell Death ◽

Cell Therapy ◽

Adoptive Cell Therapy ◽

Small Cell ◽

Small Cell Lung ◽

Programmed Death ◽

Programmed cell death protein 1/programmed death ligand-1 checkpoint blockade meets patient-derived organoids

Annals of Translational Medicine ◽

10.21037/atm.2019.11.76 ◽

2019 ◽

Vol 7 (S8) ◽

pp. S287-S287

Author(s):

Lejia Sun ◽

Huayu Yang ◽

Yilei Mao

Keyword(s):

Cell Death ◽

Programmed Cell Death ◽

Checkpoint Blockade ◽

Programmed Death ◽

Resistance Mechanisms to Programmed Cell Death Protein 1 and Programmed Death Ligand 1 inhibitors

Expert Opinion on Biological Therapy ◽

10.1080/14712598.2021.1929919 ◽

2021 ◽

Author(s):

Parmida Sadat Pezeshki ◽

Pouya Mahdavi Sharif ◽

Nima Rezaei

Keyword(s):

Cell Death ◽

Programmed Cell Death ◽

Resistance Mechanisms ◽

Programmed Death ◽

T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas

Cancer ◽

10.1002/cncr.30726 ◽

2017 ◽

Vol 123 (17) ◽

pp. 3291-3304 ◽

Cited By ~ 81

Author(s):

Seth M. Pollack ◽

Qianchuan He ◽

Jennifer H. Yearley ◽

Ryan Emerson ◽

Marissa Vignali ◽

...

Keyword(s):

Cell Death ◽

T Cell ◽

Soft Tissue ◽

Programmed Cell Death ◽

Soft Tissue Sarcomas ◽

Cell Infiltration ◽

T Cell Infiltration ◽

Programmed Death ◽

Programmed cell death protein 1/programmed death ligand 1 but not HER2 is a potential therapeutic target in gastric neuroendocrine carcinoma

Histopathology ◽

10.1111/his.14230 ◽

2020 ◽

Author(s):

Satoshi Yamashita ◽

Hiroyuki Abe ◽

Akiko Kunita ◽

Hiroharu Yamashita ◽

Yasuyuki Seto ◽

...

Keyword(s):

Cell Death ◽

Programmed Cell Death ◽

Neuroendocrine Carcinoma ◽

Therapeutic Target ◽

Potential Therapeutic Target ◽

Programmed Death ◽

Gastric Neuroendocrine Carcinoma ◽

Current Landscape of Immunotherapy Trials Involving the Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Axis in Intrathoracic Tumors

JTO Clinical and Research Reports ◽

10.1016/j.jtocrr.2021.100149 ◽

2021 ◽

Vol 2 (4) ◽

pp. 100149

Author(s):

Samuel A. Kareff ◽

Suraj Samtani ◽

Mauricio Burotto ◽

Vinay Prasad ◽

Chul Kim

Keyword(s):

Cell Death ◽

Programmed Cell Death ◽

Programmed Death ◽

Association Between Immune-Related Adverse Events and Clinical Outcomes to Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Blockade in SCLC

JTO Clinical and Research Reports ◽

10.1016/j.jtocrr.2020.100074 ◽

2020 ◽

Vol 1 (4) ◽

pp. 100074 ◽

Cited By ~ 1

Author(s):

Biagio Ricciuti ◽

Abdul Rafeh Naqash ◽

Jarushka Naidoo ◽

Kartik Sehgal ◽

Adam Miller ◽

...

Keyword(s):

Cell Death ◽

Programmed Cell Death ◽

Adverse Events ◽

Clinical Outcomes ◽

Programmed Death ◽